Omission of Surgical Axillary Staging Noninferior To Sentinel Lymph Node Biopsy in Patients with cN0, T1 or T2 Invasive Breast Cancer By Ogkologos - January 14, 2025 636 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the INSEMA study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukaemia with a Susceptible NPM1 Mutation Antitumour Activity of Patritumab Deruxtecan in Heavily Pretreated Patients with Active Brain Metastases of Breast Cancer and NSCLC EMA Recommends Extension of Indications for Sugemalimab MOST POPULAR EMA Recommends Extension of Indications for Pirtobrutinib April 24, 2025 Tomorrow is National Prescription Drug Take-Back Day! April 29, 2022 Popular Fitness Instructor Encourages Others to Maintain Routine Check Ups After... February 9, 2021 EMA Recommends Granting a Marketing Authorisation for Capivasertib April 29, 2024 Load more HOT NEWS ΟΡΘΟΚΟΛΙΚΟΣ ΚΑΡΚΙΝΟΣ How Having a Creative Outlet Helped Me Cope During Cancer Oncolytic Virus Enables the Immune System to Attack Tumors A 27-Year-Old Woman Passed Away. The Note She Wrote The Day...
